Os aspectos éticos foram respeitados 
Introduction
Hodgkin's lymphoma (HL) is a non-defining human immunodeficiency virus (HIV)-associated disease that seems to be increasing in occurrence among HIV-infected people, while other lymphomas became less frequent. 1 Chylous ascites (CA) is a condition known since 16th century, but it is an infrequent manifestation of malignancies, and it is even uncommon as presentation of HL. 2 In HIV/aids population, the occurrence of CA seems to be mainly due to infectious diseases (Table 1) . In this report, we present the first case of CA secondary to HL in a HIV-infected patient. 
Case report
Man, 42 years old, living with HIV, on irregular use of efavirenz + lamivudine + tenofovir as highly active antiretroviral therapy (HAART) since diagnosis, HIV viral load=3000 copies/mL, count TCD4=318/mL, had developed enlarging in abdominal volume six months from admission in our Infectology service, with no constitutional symptoms. HIV infection was diagnosed 2 years ago in a neurotoxoplasmosis presentation. On physical examination, he presented lipodistrophy, oedema in lower limbs (right bigger than left), temporal wasting, globose abdomen (94cm in circumference), shifting dullness to percussion, fluid waves. No signs of liver disease or palpable lymph nodes.
Ultrasonography/computed tomography imaging showed free liquid in peritoneal cavity and increased, but usual aspect retroperitoneal and mesenteric lymph nodes, discrete splenomegaly ( Figure 1 ) and no special comments for liver including venous system. Doppler venous ultrasonography showed extensive thrombosis in right common femoral vein. Study of this ascitic fluid revealed milky appearance and high triglyceride levels (708mg/dL, cell count = 1,170/mm 3 [45% neutrophils, 25% lymphocytes). Polymerase chain reaction for Mycobacterium tuberculosis, Gram stain and cultures (pyogenic and fungal) were negative in ascites, as well no neoplastic cells were found. Immunochromatographic test for filariasis was also negative. Pancreatic, liver and esophagogastroduodenoscopy showed no abnormalities. Lymphoscintigraphy resulted normal. Videolaparoscopic assessment revealed thickened peritoneum, enlarged mesenteric lymph nodes (biopsy was performed) and limited further evaluation because of the opaque liquid.
During investigation, patient was in full anticoagulation and on hipolipidic and supplemented with medium chain triglycerides diet. Although, he had evolved with weight loss and new large deep venous thrombosis (DVT) in the left leg. Additionally, this patient has left pleural effusion, which we had not punctured. Origin of this pleural effusion (cardiac, chylous or both) was not defined. Histopathologic data from mesenteric ganglia were suggestive for classic mixed cellularity HL, which was confirmed by imunohistochemistry (CD45-, CD15+, CD30+) ( Figure 2 ). Bone marrow study was negative for lymphoma infiltration. HL staging resulted in Ann Arbor IIIS. Treatment with AVBD scheme (adriamycin, vinblastine, bleomycin, dacarbazine) and maintenance of HAART resulted in reduction of abdominal volume and weight gain. At six months' evaluation patient had no complaints flaccid abdomen with 80cm of circumference, undetectable viral load and count TCD4=213/mL. We performed an integrative review of literature in Pubmed, LILACS and BIREME with "hiv OR aids AND chylous ascites OR chyloperitoneum" terms; only articles which abstract was not accessible were excluded. Results are discussed in text and summarized in Table 1 . Informed consent was obtained from the patient prior to produce this manuscript.
Discussion
CA is a rare condition (1:20,000 admissions in general hospital, but 1:2,248 HIV hospital interments) 7 first described in 1691, which has a vast differential diagnosis, 15 such as trauma, post abdominal surgery, liver cirrhosis, cancer, infectious (tuberculosis, Mycobacterium avium complex, filariasis, paracoccidioidomycosis), 16 pancreatic, yellownail syndrome, lymphatic malformation, among others. Although lymphoma is frequently remembered in differential diagnosis of CA (expected frequency of 33-50% of all cases), recent review cites frequency of 8% among adult cases, 15 and in HIV population this frequency seems to be even lower. We reviewed the all 18 published cases of CA in HIV/ aids population, most of them (15/18, 83%) caused by infectious diseases, markedly tuberculosis and Mycobacterium avium complex, in highly immunocompromised patients (mean TCD4=87cell/mL, mean age=38yr-old) ( Table 1 ). Kaposi's sarcoma 14 and non-Hodgkin's lymphoma 8 were already reported as causative diseases of CA, but to the best of our knowledge this is the first case of CA associated with classic HL in a HIV/aids patient.
Mechanisms of CA genesis in these cases are secondary to lymph node fibrosis, obstruction or both caused by malignant infiltration that leads to high pressure in pre-nodal lymphatic vessels and exudation from subserosal lymphatics into peritoneal cavity. CA is an infrequent condition and, between lymphomas, presentation with CA is more common in non-HL due to more prominent mesenteric adenopathy. 2 We believe that the higher incidence of non-HL and its preference for abdominal region justify this relation with CA, nevertheless HL in HIV/aids is usually aggressive, presenting with extra-nodal disease in 74-92%. 17 Curiously, all reported cases of CA in HIV were in men.
HL associated to HIV seems to be increasing in frequency, 1, 18 due reduction of incidence of others cancers caused by HAART. This entity has a different epidemiological profile in HIV people compared with non-HIV ones 19 : a) the incidence peak occurs ten years later; b) it has an incidence tenfold higher; c) the most common histological subtype is mixed cellularity (as this case) in contrast with nodular sclerosis in non-HIV; and d) bone marrow infiltration is more frequent. Recent data suggests no association between TCD4 or HIV counts and risk for HL. HL treatment in HIV-infected people has shown favourable outcomes compared whit pre-HAART era. Currently, complete remission is achieved in 87% of patients staged as III/IV in AVBD + HAART scheme. 19 Recurrent DVT during full anticoagulation is not frequent and suggest a highly thrombogenic status. HIV itself promotes perturbation in coagulation homeostasis (deficiency of proteins C and S, heparin cofactor II and antithrombin, among others), leading to a risk for DVT tenfold higher than HIV-negative population. 20 Also in CA patients, adding to Virchow's triad, is noted stasis caused by increase in inferior cava vein pressure (in this review we found a frequency of 19% of lower leg oedema at presentation of CA).
Conclusion
CA is a challenging symptom owning its vast differential diagnosis. We presented a case of CA secondary to HL (mixed cellularity) in a HIV-infected patient, which was never previously reported. Although in HIV/aids population infectious causes are the most common, HL should be remembered.
